85 Biggest Movers From Yesterday
Gainers
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.
54 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.
Calliditas’ Chronic Orphan Liver Disease Candidate Receives FDA Fast Track Tag
The FDA has granted Fast Track Designation to Calliditas Therapeutics AB’s (NASDAQ:CALT) lead NOX inhibitor candidate setanaxib for primary biliary cholangitis (PBC).…
Calliditas, STADA Ink Budesonide Commercialization Pact In Europe, UK For Immunoglobulin A Nephropathy
Calliditas Therapeutics AB (NASDAQ:CALT) and STADA Arzneimittel AG (OTC:STDAF) have announced a license agreement to register and commercialize Nefecon (budesonide), a chronic autoimmune…
Earnings Scheduled For May 18, 2021
Companies Reporting Before The Bell
• Agrify (NASDAQ:AGFY) is expected to report quarterly loss at $0.31 per share on revenue of $5.80 million.